• PRODUCTS
    • Assay Kit Platform & Formats
    • All Receptor Assays
    • Environmental Monitoring Assays
    • Growth Factor Assays
    • Ortholog Receptor Assays
    • Toxicology Assays
      • In Vitro Hepatotoxicity Assay Kit
      • Gene Expression Profiling Assay Kit
      • P-gp/MDR1 Drug Interaction Assay Kit
    • INDIGlo Luciferase Detection Reagent
    • Live Cell Multiplex
  • SERVICES
    • Reporter Assay Services
    • Nuclear Hormone Receptor Profiling
    • Environmental Monitoring Services
    • Gene Expression Profiling Services
    • In Vitro Hepatotoxicity Screening Services
    • Custom Assay Development
  • APPLICATIONS
    • Drug Discovery
    • Discovery Toxicology
    • Disease States
      • Overview
      • Anemia & Kidney Disease
      • Autoimmune Disease & Inflammation
      • Cancer
      • Cardiovascular Disease
      • Diabetes
      • Endocrinology
      • NAFLD/NASH
      • Obesity
    • Environmental Monitoring Applications
  • RESOURCES
    • Nuclear Receptor Overview
    • Webinars and Publications
      • New Research Publications
      • Webinars from INDIGO
      • Scientific Whitepapers from INDIGO
      • Scientific Posters from INDIGO
      • BLOG
    • Product Literature
      • INDIGO Technical Manuals
      • Product SDS
      • upcyte® Hepatocytes
    • FAQ
  • ABOUT
    • About INDIGO
    • Why INDIGO
    • Key Personnel
      • Board of Directors & Advisors
      • Management
    • Employment
    • INDIGO Press Releases
    • INDIGO in the News
  • CONTACT
    • Contact INDIGO
    • Request a Quote
    • Ordering & Distributors
Search site...

± α β γ δ Δ ε ζ κ ω ö ® ™ µ

  • PRODUCTS
    • Assay Kit Platform & Formats
    • All Receptor Assays
    • Environmental Monitoring Assays
    • Growth Factor Assays
    • Ortholog Receptor Assays
    • Toxicology Assays
      • In Vitro Hepatotoxicity Assay Kit
      • Gene Expression Profiling Assay Kit
      • P-gp/MDR1 Drug Interaction Assay Kit
    • INDIGlo Luciferase Detection Reagent
    • Live Cell Multiplex
  • SERVICES
    • Reporter Assay Services
    • Nuclear Hormone Receptor Profiling
    • Environmental Monitoring Services
    • Gene Expression Profiling Services
    • In Vitro Hepatotoxicity Screening Services
    • Custom Assay Development
  • APPLICATIONS
    • Drug Discovery
    • Discovery Toxicology
    • Disease States
      • Overview
      • Anemia & Kidney Disease
      • Autoimmune Disease & Inflammation
      • Cancer
      • Cardiovascular Disease
      • Diabetes
      • Endocrinology
      • NAFLD/NASH
      • Obesity
    • Environmental Monitoring Applications
  • RESOURCES
    • Nuclear Receptor Overview
    • Webinars and Publications
      • New Research Publications
      • Webinars from INDIGO
      • Scientific Whitepapers from INDIGO
      • Scientific Posters from INDIGO
      • BLOG
    • Product Literature
      • INDIGO Technical Manuals
      • Product SDS
      • upcyte® Hepatocytes
    • FAQ
  • ABOUT
    • About INDIGO
    • Why INDIGO
    • Key Personnel
      • Board of Directors & Advisors
      • Management
    • Employment
    • INDIGO Press Releases
    • INDIGO in the News
  • CONTACT
    • Contact INDIGO
    • Request a Quote
    • Ordering & Distributors

New Environmental Monitoring and Toxicology Assays

INDIGO’s New Family of Assays for Environmental Monitoring and Toxicology Provide a Screening Tool for Endocrine Disrupting Chemicals State College, PA (May 18, 2023) – Today INDIGO Biosciences released a new family of cell-based luciferase reporter assays specifically developed for use in environmental testing applications such as screening samples for endocrine disrupting chemicals. The assaysRead More

INDIGO Biosciences Releases Reporter Assays for Insulin Receptor and Insulin-like Growth Factor 1 Receptor

Two New Assays for Preclinical Research of Cancer, Diabetes, and Cardiovascular Disease State College, PA (17 April 2023) – INDIGO Biosciences announced today the release of two new cell-based reporter assays for the Insulin Receptor, isoform B (INSRb) and Insulin-like Growth Factor 1 Receptor (IGF-1R), both members of the receptor tyrosine kinase (RTK) family. “TheseRead More

INDIGO Biosciences Announces Record Year for 2022

Cell-Based Assay Solutions Provider Books Another Year of Record Growth State College, PA (February 22, 2023) – INDIGO Biosciences, Inc. (INDIGO), best known for its portfolio of cell-based luciferase reporter assays, experienced a record year of growth in 2022, with annual revenue 22% percent higher than 2021. “INDIGO provides exceptional value to the industries weRead More

TrkA Activation Dose Response

Human Tropomyosin Receptor Kinase TrkA, TrkB, TrkC Assays Now Available

Assays for Human Tropomyosin Receptor Kinases Developed to Help Identify Inhibitors and Activators of Nerve Growth Factor Receptors State College, PA (January 3, 2023) – INDIGO Biosciences announced today the release of three new cell-based luciferase reporter assays for Human Tropomyosin Receptor Kinases TrkA (NTRK1), TrkB (NTRK2), and TrkC (NTRK3). TrkA, TrkB, and TrkC—also knownRead More

Next Page »
Search site...
Click to Insert Symbols in Search

α β γ δ Δ ε ζ κ ® ™ µ

Request a Quote

Want More Information?

Resource Quick Links

  • Technical Manuals & Product Listing
  • Safety Data Sheets
  • Sample Study Report
  • Study Work Order Form

3006 Research Drive, Suite A1, State College, PA, USA 16801

+1 (814) 234-1919

  • Terms Conditions
  • Privacy Policy
  • Product Policies
  • Limited Use Disclosure

© 2022 INDIGO Biosciences, Inc. All Rights Reserved